RTsafe and Biomedic Medical Group sign exclusive agreement for distribution

28July 2021

RTsafe, a medical technology company focused on improving the safety and accuracy of radiotherapy for cancer and other medical conditions, today announced that Biomedic Medical Group will be the exclusive distributor of RTsafe’s products in China.

We are delighted to announce this new collaboration and looking forward to provide our products to the Chinese radiotherapy professionals.


About Biomedic Medical Group

Biomedic Medical Group is an international medical technology group enterprise. The group is committed to connecting the Chinese and international medical technology markets, integrating global related high-quality and advanced product technologies according to the actual needs of doctors and patients, so that medical technology can improve the quality of human life. The main products we provide cover many fields such as minimally invasive tumor intervention, vascular intervention, radiotherapy, radiology and ultrasound diagnosis, surgical operation and interventional consumables, orthopedic rehabilitation consumables.


About RTsafe

RTsafe is a medical technology company that has developed a unique approach to quality assurance that significantly enhances the safety and accuracy of radiotherapy for cancer and other medical conditions. It combines proven expertise in medical physics with highly accurate 3D printing technology to create pseudo‐in‐vivo dosimetry phantoms towards End‐to‐End commissioning, benchmarking and patient‐specific quality assurance in SRS, IMRT, VMAT and SBRT applications. The anatomically accurate effigies enable medical professionals to plan more precise treatment interventions for each individual patient and help radiotherapy technology innovators to fine‐tune their products. The result is more effective individualized therapy and reduced patient risk.

For more information, visit

Explore our Products
& Services
  • 29March 2023

    RTsafe to exhibit at ESTRO 2023 in Vienna

    Read More
  • 13February 2023

    RTsafe announces first use of its PseudoPatient patient-specific quality assurance process by Fundación Instituto Valenciano de Oncología (IVO)

    Read More

Request a quote

ΕΣΠΑ Banner